🧪
hypothesis

Astrocytic MEGF10 Upregulation for Selective Synaptic Engulfment Control

Hypothesis

Astrocytic MEGF10 Upregulation for Selective Synaptic Engulfment Control

Astrocytes express multiple phagocytic receptors including MEGF10 (multiple EGF-like domains 10) that enable direct synaptic material engulfment independent of microglial activation.
🧬 MEGF10🩺 connectomics🎯 Composite 35%💱 $0.44▲18.5%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 5 support 4 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.34 (15%) Novelty 0.35 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.29 (10%) Safety 0.25 (8%) Competition 0.31 (6%) Data Avail. 0.59 (5%) Reproducible 0.10 (5%) KG Connect 0.50 (8%) 0.354 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite35%

🧪 Overview

Astrocytes express multiple phagocytic receptors including MEGF10 (multiple EGF-like domains 10) that enable direct synaptic material engulfment independent of microglial activation. This hypothesis proposes that targeted upregulation of astrocytic MEGF10 expression can provide more precise temporal and spatial control over synaptic pruning compared to microglial TREM2 activation. MEGF10 functions through recognition of phosphatidylserine exposure on synaptic terminals marked for elimination, triggering astrocytic process extension and direct engulfment of synaptic material. Unlike the inflammatory cascades associated with microglial activation, astrocytic MEGF10-mediated pruning operates through gentler phagocytic mechanisms that preserve local tissue architecture. The hypothesis predicts that astrocyte-specific MEGF10 overexpression using GFAP-driven vectors will enhance developmental synaptic refinement in neural circuits while avoiding the potential neuroinflammatory side effects of microglial stimulation.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Amyloid-beta Plaques<br/>Phospholipid Ligands"]
    B["TREM2 Receptor<br/>Ligand Binding"]
    C["TYROBP/DAP12<br/>ITAM Phosphorylation"]
    D["SYK Kinase<br/>Activation"]
    E["PLCG2<br/>IP3 + DAG Generation"]
    F["Ca2+ Release<br/>Cytoskeletal Remodeling"]
    G["Microglial Phagocytosis<br/>Plaque Compaction"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix5 supports4 contradicts
Supports
TREM2 loss-of-function variants increase AD risk 2-4 fold
PMID:26928458
Supports
TREM2 is required for microglial response to amyloid plaques
PMID:26551527
Supports
TREM2 agonist promotes microglial clustering around plaques and reduces neurite dystrophy
PMID:31171641
Supports
Hub regions show heightened connectivity burden correlating with pathology
PMID:19219025
Supports
Synaptic loss in AD correlates with dysregulated microglial surveillance
PMID:29186337
Contradicts
AL002c (TREM2 agonist) failed to meet primary endpoint in INVOKE-2 Phase 2 trial (2024)
PMID:38427984
Contradicts
TREM2 deficiency reduces amyloid pathology in some contexts (reduced microglial clustering)
PMID:29307019
Contradicts
Microglial states in AD are heterogeneous - single pathway modulation insufficient
PMID:31249461
Contradicts
Mouse-to-human microglial translation limitations affect validity
PMID:29422609
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — MEGF10

No curated PDB or AlphaFold mapping for MEGF10 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for MEGF10 from GTEx v10.

Spinal cord cervical c-116.5 Caudate basal ganglia10.2 Putamen basal ganglia9.0 Nucleus accumbens basal ganglia8.6 Substantia nigra8.0 Amygdala7.5 Hippocampus6.2 Frontal Cortex BA96.1 Cortex6.1 Anterior cingulate cortex BA245.8 Cerebellum4.8 Hypothalamus4.7 Cerebellar Hemisphere4.3median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for MEGF10 →

No DepMap CRISPR Chronos data found for MEGF10.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.6%
Volatility
Low
0.0037
Events (7d)
2
Price History
▲18.5%

💾 Resource Usage

LLM Tokens
47,826
$0.1435
Total Cost
$0.1435

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we directly compare astrocyte-targeted MEGF10 overexpression versus microglial TREM2 activation (via PLX3397 diet + AAV-TREM2) in juvenile mice (P21-P35), THEN the MEGF10 condition will show equivaMEGF10 overexpression achieves comparable synaptic pruning efficiency to TREM2 activation while maintaining microglial surveillance state; serum cytokine levels— no observation —pending0.58
IF we inject GFAP-driven AAV-MEGF10 into adult mouse prefrontal cortex to overexpress astrocytic MEGF10 (compared to AAV-GFP control), THEN synaptic density will decrease by ≥15% and PSD95 puncta willSignificant reduction in excitatory synaptic markers (PSD95, vGLUT1) and decreased dendritic spine density in the injected region, without elevation of inflamma— no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we inject GFAP-driven AAV-MEGF10 into adult mouse prefrontal cortex to overexpress astrocytic MEGF10 (compared to AAV-GFP control), THEN synaptic density will decrease by ≥15% and PSD95 puncta will be reduced by ≥20% within 6 weeks post-injection.
Predicted outcome: Significant reduction in excitatory synaptic markers (PSD95, vGLUT1) and decreased dendritic spine density in the injected region, without elevation o
Falsification: Synaptic density remains unchanged (±5% of control) OR inflammatory marker expression increases >50% above control levels, indicating either failed MEGF10-mediated pruning or inflammatory off-target e
pendingconf 58%
IF we directly compare astrocyte-targeted MEGF10 overexpression versus microglial TREM2 activation (via PLX3397 diet + AAV-TREM2) in juvenile mice (P21-P35), THEN the MEGF10 condition will show equivalent synaptic pruning (≥15% reduction in vGLUT1+PSD95 colocalization) with significantly lower micro
Predicted outcome: MEGF10 overexpression achieves comparable synaptic pruning efficiency to TREM2 activation while maintaining microglial surveillance state; serum cytok
Falsification: MEGF10 overexpression fails to reduce synaptic markers by at least 15% (pruning inefficiency) OR CD68/Iba1 ratio in MEGF10 condition exceeds 1.5 (inflammatory involvement), disproving astrocyte-specif
View on SciDEX ↗